Guidance of $275 million to $300 million. Which means second half guidance of $150 million to $180 million. First half was pretty bad though.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025